| Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-β1 and upregulate expression of regulatory molecules on T cells: do they … M Razmkhah, M Jaberipour, N Erfani, M Habibagahi, A Talei, A Ghaderi Cellular immunology 266 (2), 116-122, 2011 | 137 | 2011 |
| Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran A Rezaianzadeh, J Peacock, D Reidpath, A Talei, SV Hosseini, ... BMC cancer 9, 1-11, 2009 | 130 | 2009 |
| Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer N Erfani, M Razmkhah, AR Talei, AM Pezeshki, M Doroudchi, A Monabati, ... Cancer genetics and cytogenetics 165 (2), 114-120, 2006 | 104 | 2006 |
| Cytotoxic T lymphocyte antigen-4 gene in breast cancer A Ghaderi, F Yeganeh, T Kalantari, AR Talei, A Mohammad Pezeshki, ... Breast cancer research and treatment 86, 1-7, 2004 | 93 | 2004 |
| Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes Z Faghih, N Erfani, MR Haghshenas, A Safaei, AR Talei, A Ghaderi Immunology letters 158 (1-2), 57-65, 2014 | 92 | 2014 |
| Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma M Razmkhah, AR Talei, M Doroudchi, T Khalili-Azad, A Ghaderi Cancer letters 225 (2), 261-266, 2005 | 82 | 2005 |
| Polymorphism in the genes of alpha and beta tumor necrosis factors (TNF-α and TNF-β) and gamma interferon (IFN-γ) among Iranian women with breast cancer E Kamali-Sarvestani, A Merat, AR Talei Cancer letters 223 (1), 113-119, 2005 | 82 | 2005 |
| Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women B Khadang, MJ Fattahi, A Talei, AS Dehaghani, A Ghaderi Cancer genetics and cytogenetics 173 (1), 38-42, 2007 | 75 | 2007 |
| Increased CTLA-4 and FOXP3 transcripts in peripheral blood mononuclear cells of patients with breast cancer M Jaberipour, M Habibagahi, A Hosseini, SR Habibabad, A Talei, ... Pathology & Oncology Research 16, 547-551, 2010 | 62 | 2010 |
| Program death 1 (PD1) haplotyping in patients with breast carcinoma MR Haghshenas, S Naeimi, A Talei, A Ghaderi, N Erfani Molecular biology reports 38, 4205-4210, 2011 | 48 | 2011 |
| HLA-DRB 1 alleles and the susceptibility of Iranian patients with breast cancer A Ghaderi, A Talei, B Gharesi-Fard, SH Farjadian, A Amirzargar, M Vasei Pathology oncology research 7, 39-41, 2001 | 47 | 2001 |
| Postmenopausal breast cancer in Iran; risk factors and their population attributable fractions R Ghiasvand, S Bahmanyar, K Zendehdel, S Tahmasebi, A Talei, ... BMC cancer 12, 1-9, 2012 | 44 | 2012 |
| Impact of modified radical mastectomy on health-related quality of life in women with early stage breast cancer. N Hadi, S Soltanipour, A Talei Archives of Iranian Medicine (AIM) 15 (8), 2012 | 44 | 2012 |
| The efficacy and safety of neoadjuvant chemotherapy+/− letrozole in postmenopausal women with locally advanced breast cancer: a randomized phase III clinical trial M Mohammadianpanah, Y Ashouri, S Hoseini, N Amadloo, A Talei, ... Breast cancer research and treatment 132, 853-861, 2012 | 44 | 2012 |
| Primary squamous cell carcinoma of the thyroid diagnosed by fine needle aspiration cytology. A report of two cases. PV Kumar, SA Malekhusseini, AR Talei Acta cytologica 43 (4), 659-662, 1999 | 44 | 1999 |
| The effect of combined decongestive therapy and pneumatic compression pump on lymphedema indicators in patients with breast cancer related lymphedema M Moattari, B Jaafari, A Talei, S Piroozi, S Tahmasebi, Z Zakeri Iranian Red Crescent Medical Journal 14 (4), 210, 2012 | 43 | 2012 |
| Memory CD4+ T cell subsets in tumor draining lymph nodes of breast cancer patients: A focus on T stem cell memory cells Y Vahidi, Z Faghih, AR Talei, M Doroudchi, A Ghaderi Cellular Oncology 41, 1-11, 2018 | 42 | 2018 |
| Breast cancer risk factors in women participating in a breast screening program: a study on 11,850 Iranian females M Sepandi, M Akrami, H Tabatabaee, A Rajaeefard, S Tahmasebi, ... Asian Pacific Journal of Cancer Prevention 15 (19), 8499-8502, 2014 | 40 | 2014 |
| Association of Interleukin18 gene promoter polymorphisms with breast cancer M Razmkhah, M Doroudchi, Z Mojtahedi, A Ghaderi Neoplasma 56 (1), 10.4149, 2009 | 40 | 2009 |
| Ile to Val polymorphism at codon 655 of HER-2 gene and breast cancer risk in Iranian women E Kamali-Sarvestani, AR Talei, A Merat Cancer letters 215 (1), 83-87, 2004 | 40 | 2004 |
